Jackson Creek Investment Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,858
Closed -$1.47M 337
2025
Q4
$1.47M Sell
21,858
-1,277
-6% -$85.9K 0.43% 112
2025
Q3
$1.7M Sell
23,135
-9
-0% -$598 0.49% 90
2025
Q2
$1.2M Sell
23,144
-3,268
-12% -$186K 0.32% 164
2025
Q1
$1.69M Sell
26,412
-14
-0.1% -$813 0.54% 29
2024
Q4
$1.26M Buy
+26,426
New +$1.36M 0.38% 144
2022
Q3
Sell
-18,847
Closed -$922K 318
2022
Q2
$922K Buy
+18,847
New +$815K 0.37% 142
2022
Q1
Sell
-25,132
Closed -$1.01M 322
2021
Q4
$1.01M Sell
25,132
-1,755
-7% -$65.5K 0.36% 146
2021
Q3
$1.09M Buy
+26,887
New +$1.12M 0.41% 99
2021
Q2
Sell
-27,633
Closed -$1.15M 326
2021
Q1
$1.15M Sell
27,633
-821
-3% -$37.5K 0.4% 101
2020
Q4
$1.22M Sell
28,454
-11,973
-30% -$430K 0.48% 40
2020
Q3
$1.06M Buy
+40,427
New +$1.13M 0.48% 28

Other funds holding HALO

Jackson Creek Investment Advisors's HALO Position: Q1 2026 in Review

Jackson Creek Investment Advisors sold out of Halozyme (HALO) in Q1 2026, closing a stake of 21,858 shares — an estimated $1.47M sold.

Jackson Creek Investment Advisors first reported a position in HALO in Q3 2020 and held it in 11 quarters. The position peaked at $1.7M in Q3 2025. 636 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Jackson Creek Investment Advisors reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 21,858 Halozyme shares in Q1 2026, an estimated $1.47M.
  • Jackson Creek Investment Advisors first reported a position in Halozyme in Q3 2020 and held it in 11 quarters.
  • Jackson Creek Investment Advisors's Halozyme position peaked at $1.7M in Q3 2025.
  • 636 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.